Washington Trust Advisors Inc. Cuts Stock Position in Intuitive Surgical, Inc. (NASDAQ:ISRG)

Washington Trust Advisors Inc. reduced its position in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 3.4% in the fourth quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 19,287 shares of the medical equipment provider’s stock after selling 674 shares during the quarter. Washington Trust Advisors Inc.’s holdings in Intuitive Surgical were worth $10,067,000 at the end of the most recent quarter.

A number of other hedge funds and other institutional investors have also recently modified their holdings of the company. State Street Corp boosted its holdings in shares of Intuitive Surgical by 1.4% in the 3rd quarter. State Street Corp now owns 15,050,121 shares of the medical equipment provider’s stock worth $7,393,673,000 after purchasing an additional 210,363 shares in the last quarter. FMR LLC lifted its stake in shares of Intuitive Surgical by 8.3% in the 3rd quarter. FMR LLC now owns 10,971,085 shares of the medical equipment provider’s stock valued at $5,389,765,000 after acquiring an additional 838,793 shares during the last quarter. Geode Capital Management LLC lifted its stake in shares of Intuitive Surgical by 1.9% in the 3rd quarter. Geode Capital Management LLC now owns 7,512,925 shares of the medical equipment provider’s stock valued at $3,677,194,000 after acquiring an additional 143,440 shares during the last quarter. Fisher Asset Management LLC lifted its stake in shares of Intuitive Surgical by 1.8% in the 4th quarter. Fisher Asset Management LLC now owns 4,868,869 shares of the medical equipment provider’s stock valued at $2,541,356,000 after acquiring an additional 86,488 shares during the last quarter. Finally, Baillie Gifford & Co. lifted its stake in shares of Intuitive Surgical by 0.6% in the 3rd quarter. Baillie Gifford & Co. now owns 3,848,547 shares of the medical equipment provider’s stock valued at $1,890,676,000 after acquiring an additional 24,183 shares during the last quarter. 83.64% of the stock is currently owned by hedge funds and other institutional investors.

Analyst Ratings Changes

A number of equities research analysts have recently weighed in on the company. Stifel Nicolaus boosted their target price on Intuitive Surgical from $525.00 to $610.00 and gave the company a “buy” rating in a research note on Thursday, December 5th. Citigroup boosted their target price on Intuitive Surgical from $640.00 to $711.00 and gave the company a “buy” rating in a research note on Friday, January 24th. Truist Financial boosted their target price on Intuitive Surgical from $640.00 to $666.00 and gave the company a “buy” rating in a research note on Friday, January 24th. Jefferies Financial Group boosted their target price on Intuitive Surgical from $475.00 to $575.00 in a research note on Monday, January 27th. Finally, JPMorgan Chase & Co. boosted their target price on Intuitive Surgical from $575.00 to $675.00 and gave the company an “overweight” rating in a research note on Friday, January 24th. One investment analyst has rated the stock with a sell rating, four have given a hold rating and sixteen have issued a buy rating to the company’s stock. According to data from MarketBeat, Intuitive Surgical currently has a consensus rating of “Moderate Buy” and an average price target of $613.10.

Insider Buying and Selling

In related news, CFO Jamie Samath sold 94 shares of the company’s stock in a transaction that occurred on Wednesday, January 29th. The stock was sold at an average price of $571.11, for a total value of $53,684.34. Following the sale, the chief financial officer now owns 2,630 shares in the company, valued at $1,502,019.30. This represents a 3.45 % decrease in their position. The transaction was disclosed in a filing with the SEC, which is available at this hyperlink. Also, EVP Myriam Curet sold 408 shares of Intuitive Surgical stock in a transaction on Tuesday, February 11th. The stock was sold at an average price of $589.75, for a total value of $240,618.00. Following the completion of the sale, the executive vice president now directly owns 353 shares of the company’s stock, valued at approximately $208,181.75. The trade was a 53.61 % decrease in their position. The disclosure for this sale can be found here. Insiders have sold 12,598 shares of company stock worth $7,223,467 in the last 90 days. Insiders own 0.90% of the company’s stock.

Intuitive Surgical Stock Up 1.8 %

Intuitive Surgical stock opened at $568.02 on Thursday. The company has a market capitalization of $202.32 billion, a P/E ratio of 88.61, a PEG ratio of 5.85 and a beta of 1.43. The stock’s 50 day moving average is $571.70 and its 200 day moving average is $530.90. Intuitive Surgical, Inc. has a twelve month low of $364.17 and a twelve month high of $616.00.

Intuitive Surgical Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.